Life Sciences 2022 Roundup and 2023 Outlook
Time: 2:00-3:30 PM ET
* Please Note: registration closes at 11:59 PM ET the day before the live event. No further registrations will be accepted once registration has been closed *
Overview: In this webinar, panelists will discuss trending issues and developments for the life sciences industry from the past year and what we expect to see in 2023. We will consider research, development, and commercial issues related to the regulation of drugs, biotech, and medical devices. Topics will include digital health tools and solutions, use of social media and tracking technologies, drug pricing legislation, drug promotion and scientific exchange, and conflict of interest issues in industry-academic partnerships.
Leslie Thornton, Ph.D., J.D., Counsel, Ropes & Gray LLP
Stefanie Doebler, Partner, Co-Chair of Health Care Practice Group, Covington & Burling LLP
CLE: AHLA’s live distance learning webinars are pre-approved for CLE credit in the following states: AL, IL, KS, ME, MS, NE, NJ, OH, OK, PA, RI, SC, TN, TX, VA, WI, and WV. Please refer to the Distance Learning CLE State Chart on our Continuing Education page to review the reporting procedure in these state
CPE: AHLA is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Nashville, TN 37219-2417. Website: www.nasba.org. For further information, please visit our Continuing Education Page.
AHLA is seeking CPE credits for live and on demand webinars. The maximum number of credits available is 1.80.